Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$28.89
+0.5%
$33.75
$27.18
$51.12
$2.27B1.17858,626 shs1.47 million shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$99.99
+1.0%
$100.98
$78.28
$212.43
$2.44B0.72194,470 shs165,174 shs
Inari Medical, Inc. stock logo
NARI
Inari Medical
$42.03
+0.1%
$43.12
$36.73
$71.85
$2.44B0.931.20 million shs1.06 million shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$44.72
+22.3%
$32.29
$13.82
$47.00
$2.89B1.11.28 million shs5.99 million shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
+0.49%+1.94%-14.78%-28.08%-43.74%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+0.96%+5.43%-3.26%+9.83%-46.72%
Inari Medical, Inc. stock logo
NARI
Inari Medical
+0.10%+9.40%-2.78%-27.41%-33.21%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+22.32%+26.90%+30.53%+92.59%+11.94%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.7974 of 5 stars
3.13.00.04.02.81.73.8
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.7929 of 5 stars
2.51.00.03.92.62.51.9
Inari Medical, Inc. stock logo
NARI
Inari Medical
3.4657 of 5 stars
4.43.00.00.01.73.30.6
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
3.1928 of 5 stars
2.32.00.04.93.40.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.22
Hold$44.8955.38% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0023.01% Upside
Inari Medical, Inc. stock logo
NARI
Inari Medical
2.71
Moderate Buy$65.7156.35% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.64
Moderate Buy$43.45-2.83% Downside

Current Analyst Ratings

Latest TNDM, IART, NARI, and ICUI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$35.00 ➝ $50.00
5/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$28.00 ➝ $36.00
5/1/2024
Inari Medical, Inc. stock logo
NARI
Inari Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $55.00
5/1/2024
Inari Medical, Inc. stock logo
NARI
Inari Medical
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $84.00
5/1/2024
Inari Medical, Inc. stock logo
NARI
Inari Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$55.00 ➝ $50.00
5/1/2024
Inari Medical, Inc. stock logo
NARI
Inari Medical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$72.00 ➝ $57.00
4/29/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$21.00 ➝ $45.00
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$34.00 ➝ $45.00
4/23/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$37.00 ➝ $40.00
4/12/2024
Inari Medical, Inc. stock logo
NARI
Inari Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.54B1.47$4.86 per share5.95$20.31 per share1.42
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.08$15.45 per share6.47$87.96 per share1.14
Inari Medical, Inc. stock logo
NARI
Inari Medical
$493.63M4.95$0.09 per share476.22$7.69 per share5.47
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$747.72M3.86N/AN/A$4.81 per share9.30

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M$0.8334.818.000.874.39%15.19%6.59%5/6/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A18.59N/A-1.31%6.35%3.03%5/7/2024 (Confirmed)
Inari Medical, Inc. stock logo
NARI
Inari Medical
-$1.64M-$0.41N/A210.15N/A-4.54%-1.65%-1.23%8/7/2024 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$2.17N/AN/AN/A-18.37%-32.33%-10.90%8/1/2024 (Estimated)

Latest TNDM, IART, NARI, and ICUI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.8350N/A-$0.8350N/AN/AN/A  
5/6/2024N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.55N/A-$0.55N/AN/AN/A  
2/28/202412/31/2023
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.90$0.89-$0.01$1.53$399.30 million$397.00 million    
2/28/202412/31/2023
Inari Medical, Inc. stock logo
NARI
Inari Medical
$0.01-$0.08-$0.09$0.18$131.82 million$132.10 million    
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/21/2024Q4 2023
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.23-$0.27-$0.04-$0.08$204.86 million$196.80 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.94
3.45
2.18
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/A
2.71
2.52
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.91
3.83
3.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Inari Medical, Inc. stock logo
NARI
Inari Medical
90.98%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
6.70%
Inari Medical, Inc. stock logo
NARI
Inari Medical
10.60%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94678.60 million76.17 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
Inari Medical, Inc. stock logo
NARI
Inari Medical
1,30058.14 million51.98 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,40064.56 million63.14 millionOptionable

TNDM, IART, NARI, and ICUI Headlines

SourceHeadline
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 52-Week High Following Analyst UpgradeTandem Diabetes Care (NASDAQ:TNDM) Sets New 52-Week High Following Analyst Upgrade
americanbankingnews.com - May 4 at 1:38 AM
Why Tandem Diabetes Stock Just Jumped 22%Why Tandem Diabetes Stock Just Jumped 22%
fool.com - May 3 at 4:34 PM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call TranscriptTandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 3 at 1:09 PM
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst UpgradeTandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst Upgrade
marketbeat.com - May 3 at 12:51 PM
Tandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper SandlerTandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper Sandler
marketbeat.com - May 3 at 11:12 AM
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises 24 ViewTandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
zacks.com - May 3 at 10:36 AM
Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00
marketbeat.com - May 3 at 9:33 AM
Tandem Diabetes Care Shares Rise 17% on Raised 2024 Sales OutlookTandem Diabetes Care Shares Rise 17% on Raised 2024 Sales Outlook
marketwatch.com - May 3 at 8:08 AM
Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
finance.yahoo.com - May 3 at 8:08 AM
Q1 2024 Tandem Diabetes Care Inc Earnings CallQ1 2024 Tandem Diabetes Care Inc Earnings Call
finance.yahoo.com - May 3 at 8:08 AM
TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024
investorplace.com - May 2 at 10:05 PM
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesTandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - May 2 at 7:31 PM
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue EstimatesTandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
zacks.com - May 2 at 6:31 PM
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial GuidanceTandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
businesswire.com - May 2 at 4:05 PM
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)
markets.businessinsider.com - May 2 at 8:23 AM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by Wells Fargo & CompanyTandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by Wells Fargo & Company
americanbankingnews.com - May 1 at 9:46 AM
How Advanced Diabetes Supply is Driving Value-Based Health OutcomesHow Advanced Diabetes Supply is Driving Value-Based Health Outcomes
hmenews.com - April 30 at 5:21 PM
Wells Fargo Upgrades Tandem Diabetes Care (TNDM)Wells Fargo Upgrades Tandem Diabetes Care (TNDM)
msn.com - April 30 at 12:21 PM
Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?
finance.yahoo.com - April 29 at 4:19 PM
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24
marketbeat.com - April 29 at 12:12 PM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to Overweight at Wells Fargo & CompanyTandem Diabetes Care (NASDAQ:TNDM) Upgraded to Overweight at Wells Fargo & Company
marketbeat.com - April 29 at 8:06 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Leerink PartnrsTandem Diabetes Care (NASDAQ:TNDM) Upgraded at Leerink Partnrs
americanbankingnews.com - April 27 at 3:48 AM
Tandem Diabetes Care (NASDAQ:TNDM) Rating Increased to Outperform at SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) Rating Increased to Outperform at SVB Leerink
americanbankingnews.com - April 27 at 1:54 AM
Leerink Partners Upgrades Tandem Diabetes Care (TNDM)Leerink Partners Upgrades Tandem Diabetes Care (TNDM)
msn.com - April 26 at 1:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Integra LifeSciences logo

Integra LifeSciences

NASDAQ:IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Inari Medical logo

Inari Medical

NASDAQ:NARI
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Tandem Diabetes Care logo

Tandem Diabetes Care

NASDAQ:TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.